Published in FEMS Microbiol Lett on June 15, 1993
Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun (1995) 1.60
Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection. Infect Immun (2001) 1.51
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun (1994) 1.51
Identification and characterization of TspA, a major CD4(+) T-cell- and B-cell-stimulating Neisseria-specific antigen. Infect Immun (1999) 0.93
Manganese regulation of virulence factors and oxidative stress resistance in Neisseria gonorrhoeae. J Proteomics (2009) 0.90
Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet (1978) 11.99
Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol (1996) 4.45
A simple method for the detection of Chlamydia trachomatis infections in general practice. J R Coll Gen Pract (1987) 3.08
Epidemiology of experimental enterocecitis due to Clostridium difficile. J Infect Dis (1980) 2.95
Simplified procedure for the routine isolation of Clostridium difficile from faeces. J Clin Pathol (1981) 2.07
Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ (2000) 2.02
Antibiotic and pseudomembranous colitis. J Antimicrob Chemother (1981) 1.89
Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet (1984) 1.89
Clinical and bacteriological findings in necrotising enterocolitis: a controlled study. J Infect (1980) 1.80
Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther (2003) 1.73
Obstructive sleep apnea syndrome: a comparison between Far-East Asian and white men. Laryngoscope (2000) 1.65
Factors influencing antibiotic prescribing habits and use of sensitivity testing amongst veterinarians in Europe. Vet Rec (2013) 1.60
Epidemiology of diarrhoea caused by enterotoxigenic Clostridium perfringens. J Med Microbiol (1985) 1.56
Maxillofacial surgery and nasal CPAP. A comparison of treatment for obstructive sleep apnea syndrome. Chest (1990) 1.55
Usefulness of culture in the diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (1995) 1.54
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun (1994) 1.51
Molecular cloning of a 32-kilodalton lipoprotein component of a novel iron-regulated Staphylococcus epidermidis ABC transporter. Infect Immun (1998) 1.51
An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene (1997) 1.50
An in-vitro model of colonisation resistance to Clostridium difficile infection. J Med Microbiol (1986) 1.50
Clear cell odontogenic tumor--a new histologic variant with aggressive potential. Head Neck Surg (1986) 1.49
Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis. J Clin Pathol (1986) 1.38
Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains. J Med Microbiol (1985) 1.38
Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr (1984) 1.35
Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol (1985) 1.28
Isolation of Clostridium difficile from the small bowel. Br Med J (Clin Res Ed) (1981) 1.28
Concomitance of cytotoxigenic and non-cytotoxigenic Clostridium difficile in stool specimens. J Clin Microbiol (1983) 1.27
Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits. J Clin Microbiol (1983) 1.27
Analysis of latex agglutination test for Clostridium difficile toxin A (D-1) and differentiation between C difficile toxins A and B and latex reactive protein. J Clin Pathol (1987) 1.27
Fluorescent amplified-fragment length polymorphism genotyping of Neisseria meningitidis identifies clones associated with invasive disease. J Clin Microbiol (2000) 1.25
Spread of Clostridium difficile among patients receiving non-absorbable antibiotics for gut decontamination. Br Med J (Clin Res Ed) (1981) 1.22
Lignan formation in man--microbial involvement and possible roles in relation to cancer. Lancet (1981) 1.22
Proteolytic activity of Clostridium difficile. J Med Microbiol (1992) 1.20
Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg (1993) 1.19
The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Vaccine (1996) 1.18
A comparison of Asian and white patients with obstructive sleep apnea syndrome. Laryngoscope (1999) 1.17
Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction. J Med Microbiol (1989) 1.13
Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. J Med Microbiol (1987) 1.13
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol (1987) 1.12
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects. Antimicrob Agents Chemother (1995) 1.12
Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis. Mol Microbiol (2001) 1.12
Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report. Epidemiol Infect (1999) 1.11
Effect of Clostridium difficile toxin A on human colonic lamina propria cells: early loss of macrophages followed by T-cell apoptosis. Infect Immun (1998) 1.10
Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model. J Med Microbiol (1990) 1.09
Infectious diarrhea due to Clostridium perfringens. J Infect Dis (1988) 1.09
Bacteriotherapy for Clostridium difficile diarrhoea. Lancet (1989) 1.07
Impact of neonatal intensive care. Lancet (1982) 1.07
Allergy of the lower urinary tract. Ann Allergy (1970) 1.07
Obstructive sleep apnea syndrome: a surgical protocol for dynamic upper airway reconstruction. J Oral Maxillofac Surg (1993) 1.06
Household pets as a potential reservoir for Clostridium difficile infection. J Clin Pathol (1983) 1.06
Gas-liquid chromatography and Clostridium difficile. Lancet (1981) 1.06
Radiofrequency volumetric tissue reduction for treatment of turbinate hypertrophy: a pilot study. Otolaryngol Head Neck Surg (1998) 1.04
Surgery and obstructive sleep apnea: long-term clinical outcomes. Otolaryngol Head Neck Surg (2000) 1.04
Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes. Vaccine (1994) 1.04
Detection of capsule in strains of Clostridium difficile of varying virulence and toxigenicity. Microb Pathog (1990) 1.03
Comparison of different vaccines and induced immune response against Campylobacter jejuni colonization in the infant mouse. Epidemiol Infect (1989) 1.02
Characterisation of anaerobic curved rods (Mobiluncus spp.) isolated from the urogenital tract. J Med Microbiol (1987) 1.02
Obstructive sleep apnea syndrome following surgery for mandibular prognathism. J Oral Maxillofac Surg (1987) 1.02
Localization of the meningococcal receptors for human transferrin. Infect Immun (1993) 1.00
Immunogenicity and cross-reactivity of the 70-Kda iron-regulated protein of Neisseria meningitidis in man and animals. J Med Microbiol (1990) 1.00
Maxillofacial surgery and obstructive sleep apnea syndrome. Otolaryngol Clin North Am (1990) 0.99
Plasmid analysis as a means of strain differentiation in Clostridium perfringens. J Clin Microbiol (1987) 0.99
Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother (1990) 0.99
The 70 kilodalton iron regulated protein of Neisseria meningitidis is not the human transferrin receptor. FEMS Microbiol Lett (1990) 0.97
Neisserial TonB-dependent outer-membrane proteins: detection, regulation and distribution of three putative candidates identified from the genome sequences. Microbiology (2001) 0.97
Mastic gum kills Helicobacter pylori. N Engl J Med (1998) 0.96
Maxillary, mandibular, and hyoid advancement: an alternative to tracheostomy in obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg (1986) 0.96
Infectious nature of Clostridium spiroforme-mediated rabbit enterotoxaemia. Vet Microbiol (1984) 0.96
Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea. J Clin Pathol (2004) 0.95
A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells. J Immunol Methods (1998) 0.95
Characteristics of a gram-negative anaerobe isolated from men with non-gonococcal urethritis. J Med Microbiol (1984) 0.94
Comparison of methods for the analysis of outer membrane antigens of Neisseria meningitidis by western blotting. J Immunol Methods (1990) 0.94
Contribution of gut bacterial metabolism to human metabolic disease. Lancet (1988) 0.94
Use of an alcolmeter to detect problem drinkers. Br Med J (Clin Res Ed) (1982) 0.93
Radiofrequency volumetric reduction of the palate: An extended follow-up study. Otolaryngol Head Neck Surg (2000) 0.93
Auto-transporter A protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning. Mol Microbiol (2000) 0.93
Identification and characterization of TspA, a major CD4(+) T-cell- and B-cell-stimulating Neisseria-specific antigen. Infect Immun (1999) 0.93
Obstructive sleep apnea and the hyoid: a revised surgical procedure. Otolaryngol Head Neck Surg (1994) 0.92
Obstructive sleep apnea. Trends in therapy. West J Med (1995) 0.92
Maxillofacial surgery and obstructive sleep apnea: a review of 80 patients. Otolaryngol Head Neck Surg (1989) 0.91
Diarrhoea associated with toxigenic Clostridium spiroforme. J Infect (1986) 0.91
Simplified procedure for tissue culture in routine detection of cytotoxins. J Clin Pathol (1985) 0.91
Directing phage selections towards specific epitopes. Protein Eng (1996) 0.89
Clear cell odontogenic carcinoma. A clinicopathologic analysis. Arch Otolaryngol Head Neck Surg (1995) 0.88
Maxillary, mandibular, and hyoid advancement for treatment of obstructive sleep apnea: a review of 40 patients. J Oral Maxillofac Surg (1990) 0.88
Microbiology, epidemiology and diagnosis of Clostridium difficile infection. Curr Top Microbiol Immunol (2000) 0.88
Generation of a panel of related human scFv antibodies with high affinities for human CEA. Immunotechnology (1996) 0.88
Neisseria meningitidis: clinical aspects. J Infect (1997) 0.88
Inclusion of indigenous and ethnic minority populations in intervention trials: challenges and strategies in a New Zealand supermarket study. J Epidemiol Community Health (2009) 0.88
Facial contouring with outer-table calvarial bone. A 4-year experience. Arch Otolaryngol Head Neck Surg (1989) 0.88
Inferior mandibular osteotomy and hyoid myotomy suspension for obstructive sleep apnea: a review of 55 patients. J Oral Maxillofac Surg (1989) 0.88
Inhalation of nail dust from onychomycotic toenails. Part I. Characterization of particles. J Am Podiatr Med Assoc (1985) 0.88
Bacterial colonization and nitrite concentration in the achlorhydric stomachs of patients with primary hypogammaglobulinaemia or classical pernicious anaemia. Scand J Gastroenterol (1984) 0.87
Bacteria and gastrointestinal secretion and motility. Scand J Gastroenterol Suppl (1984) 0.87
Cloning, sequencing, characterisation and implications for vaccine design of the novel dihydrolipoyl acetyltransferase of Neisseria meningitidis. J Med Microbiol (1996) 0.87
The metabolism of lithocholic acid and lithocholic acid-3-alpha-sulfate by human fecal bacteria. Lipids (1982) 0.87
Identification and preliminary characterization of a cytotoxin isolated from Mobiluncus spp. Int J Exp Pathol (1993) 0.87
Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing. Euro Surveill (2013) 0.86